Walmart Reaches $50 Million Settlement with DOJ Over Opioid Prescription Allegations

Walmart Inc. agreed Friday to pay $50 million to settle a lawsuit by the U.S. Department of Justice alleging its pharmacies unlawfully dispensed opioid prescriptions, fueling the nationwide opioid epidemic.

Settlement Amount Far Below Initial Risk

The amount represents a fraction of the billions of dollars in civil penalties Walmart faced when the lawsuit was filed in December 2020. Walmart did not admit any wrongdoing and described the payment as "immaterial" in a regulatory filing.

Federal prosecutors alleged that Walmart violated the Controlled Substances Act since 2013 by ignoring "red flags" on suspicious prescriptions, with some compliance personnel allegedly aware that certain prescribers operated "pill mills."

Opioids such as oxycodone and hydrocodone are prescription drugs used to treat pain. However, their misuse and overprescription have led to widespread addiction and overdose deaths across the United States.

The Arkansas-based retailer posted a net profit of $11.79 billion in the six months ending July 31.

Walmart reported second-quarter results last week with revenue of $187.94 billion, slightly above the expected $186.71 billion. The company reported adjusted earnings per share of $0.81, beating analyst estimates of $0.74 by 9.46%.

Broader Industry Impact Continues

Federal and state authorities have pursued opioid-related cases across the entire supply chain, from manufacturer Purdue Pharma to distributors such as Cencora Inc., and retail pharmacy operators including CVS Health Corp. and Walgreens, both of which have reached significantly larger settlements.

According to the U.S. Centers for Disease Control and Prevention, approximately 806,000 people in the United States died from opioid-involved overdoses between 1999 and 2023.

In 2024, the CDC recorded 54,045 additional opioid-involved overdose deaths. Combined with the CDC's preliminary estimate of 44,564 opioid-involved overdose deaths for 2025, the cumulative number of opioid-involved overdose deaths since 1999 stands at approximately 905,000.

Trading Metrics

Walmart has a market capitalization of $820.4 billion, with a 52-week high of $135.16 and a 52-week low of $95.80.

The stock is up 7.26% over the past 12 months but down 8.58% year-to-date.

Price Action: WMT shares closed at $103.09 in regular trading Friday, up 0.45%.

With a strong growth score of 92.74, Edge stock ratings indicate Walmart shares are exhibiting negative price trends across all time frames.